Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Hypertension

Free Subscription Articles published in PLoS Med Retrieve available abstracts of 28 articles: HTML format

Single Articles

January 2024
1. ALTHOFF KN, Stewart C, Humes E, Gerace L, et al
   The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study.
   PLoS Med. 2024;21:e1004325.
   PubMed     Abstract available
   
   
   April 2023
2. SHEPPARD JP, Koshiaris C, Stevens R, Lay-Flurrie S, et al
   The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study.
   PLoS Med. 2023;20:e1004223.
   PubMed     Abstract available
   
   
   January 2023
3. PRINZ N, Putri RR, Reinehr T, Danielsson P, et al
   The association between perinatal factors and cardiometabolic risk factors in children and adolescents with overweight or obesity: A retrospective two-cohort study.
   PLoS Med. 2023;20:e1004165.
   PubMed     Abstract available
   
   
   December 2022
4. OSETINSKY B, Mhalu G, Mtenga S, Tediosi F, et al
   Care cascades for hypertension and diabetes: Cross-sectional evaluation of rural districts in Tanzania.
   PLoS Med. 2022;19:e1004140.
   PubMed     Abstract available
   
   
   
5. KOEPPEL L, Dittrich S, Brenner Miguel S, Carmona S, et al
   Addressing the diagnostic gap in hypertension through possible interventions and scale-up: A microsimulation study.
   PLoS Med. 2022;19:e1004111.
   PubMed     Abstract available
   
   
   
6. PEDRON S, Hanselmann M, Burns J, Rich A, et al
   The effect of population-based blood pressure screening on long-term cardiometabolic morbidity and mortality in Germany: A regression discontinuity analysis.
   PLoS Med. 2022;19:e1004151.
   PubMed     Abstract available
   
   
   October 2022
7. CHEN S, Conwell Y, Xue J, Li L, et al
   Effectiveness of integrated care for older adults with depression and hypertension in rural China: A cluster randomized controlled trial.
   PLoS Med. 2022;19:e1004019.
   PubMed     Abstract available
   
   
   August 2022
8. RANZANI OT, Kalra A, Di Girolamo C, Curto A, et al
   Urban-rural differences in hypertension prevalence in low-income and middle-income countries, 1990-2020: A systematic review and meta-analysis.
   PLoS Med. 2022;19:e1004079.
   PubMed     Abstract available
   
   
   June 2022
9. JAFAR TH, Tan NC, Shirore RM, Allen JC, et al
   Integration of a multicomponent intervention for hypertension into primary healthcare services in Singapore-A cluster randomized controlled trial.
   PLoS Med. 2022;19:e1004026.
   PubMed     Abstract available
   
   
   April 2022
10. CARRILLO-LARCO RM, Guzman-Vilca WC, Neupane D
    Simplified hypertension screening methods across 60 countries: An observational study.
    PLoS Med. 2022;19:e1003975.
    PubMed     Abstract available
    
    
    March 2022
11. HESHMATOLLAH A, Ma Y, Fani L, Koudstaal PJ, et al
    Visit-to-visit blood pressure variability and the risk of stroke in the Netherlands: A population-based cohort study.
    PLoS Med. 2022;19:e1003942.
    PubMed     Abstract available
    
    
    February 2022
12. YARMOLINSKY J, Diez-Obrero V, Richardson TG, Pigeyre M, et al
    Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
    PLoS Med. 2022;19:e1003897.
    PubMed     Abstract available
    
    
    January 2022
13. LEE J, Wilkens J, Meijer E, Sekher TV, et al
    Hypertension awareness, treatment, and control and their association with healthcare access in the middle-aged and older Indian population: A nationwide cohort study.
    PLoS Med. 2022;19:e1003855.
    PubMed     Abstract available
    
    
    November 2021
14. SARKAR C, Lai KY, Ni MY, Kumari S, et al
    Liveable residential space, residential density, and hypertension in Hong Kong: A population-based cohort study.
    PLoS Med. 2021;18:e1003824.
    PubMed     Abstract available
    
    
    
15. STENBERG E, Marsk R, Sundbom M, Ottosson J, et al
    Remission, relapse, and risk of major cardiovascular events after metabolic surgery in persons with hypertension: A Swedish nationwide registry-based cohort study.
    PLoS Med. 2021;18:e1003817.
    PubMed     Abstract available
    
    
    
16. EPELBOIN S, Labrosse J, De Mouzon J, Fauque P, et al
    Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study.
    PLoS Med. 2021;18:e1003857.
    PubMed     Abstract available
    
    
    September 2021
17. HICKEY MD, Ayieko J, Owaraganise A, Sim N, et al
    Effect of a patient-centered hypertension delivery strategy on all-cause mortality: Secondary analysis of SEARCH, a community-randomized trial in rural Kenya and Uganda.
    PLoS Med. 2021;18:e1003803.
    PubMed     Abstract available
    
    
    
18. HUANG C, Li J, Qin G, Liew Z, et al
    Maternal hypertensive disorder of pregnancy and offspring early-onset cardiovascular disease in childhood, adolescence, and young adulthood: A national population-based cohort study.
    PLoS Med. 2021;18:e1003805.
    PubMed     Abstract available
    
    
    August 2021
19. MOHANTY SK, Pedgaonkar SP, Upadhyay AK, Kampfen F, et al
    Awareness, treatment, and control of hypertension in adults aged 45 years and over and their spouses in India: A nationally representative cross-sectional study.
    PLoS Med. 2021;18:e1003740.
    PubMed     Abstract available
    
    
    July 2021
20. WEI X, Zhang Z, Chong MKC, Hicks JP, et al
    Evaluation of a package of risk-based pharmaceutical and lifestyle interventions in patients with hypertension and/or diabetes in rural China: A pragmatic cluster randomised controlled trial.
    PLoS Med. 2021;18:e1003694.
    PubMed     Abstract available
    
    
    
21. LIU CH, Sung PS, Li YR, Huang WK, et al
    Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort study.
    PLoS Med. 2021;18:e1003707.
    PubMed     Abstract available
    
    
    June 2021
22. TRAN J, Norton R, Canoy D, Ayala Solares JR, et al
    Multi-morbidity and blood pressure trajectories in hypertensive patients: A multiple landmark cohort study.
    PLoS Med. 2021;18:e1003674.
    PubMed     Abstract available
    
    
    
23. GUE YX, Lip GYH
    Hypertension and atrial fibrillation: Closing a virtuous circle.
    PLoS Med. 2021;18:e1003598.
    PubMed     Abstract available
    
    
    
24. PINHO-GOMES AC, Azevedo L, Copland E, Canoy D, et al
    Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
    PLoS Med. 2021;18:e1003599.
    PubMed     Abstract available
    
    
    May 2021
25. PERSAUD N, Bedard M, Boozary A, Glazier RH, et al
    Adherence at 2 years with distribution of essential medicines at no charge: The CLEAN Meds randomized clinical trial.
    PLoS Med. 2021;18:e1003590.
    PubMed     Abstract available
    
    
    April 2021
26. KIRKEGAARD H, Bliddal M, Stovring H, Rasmussen KM, et al
    Maternal weight change from prepregnancy to 18 months postpartum and subsequent risk of hypertension and cardiovascular disease in Danish women: A cohort study.
    PLoS Med. 2021;18:e1003486.
    PubMed     Abstract available
    
    
    March 2021
27. LI C, Chen K, Cornelius V, Tomeny E, et al
    Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.
    PLoS Med. 2021;18:e1003515.
    PubMed     Abstract available
    
    
    January 2021
28. RAMAKRISHNAN R, Doherty A, Smith-Byrne K, Rahimi K, et al
    Accelerometer measured physical activity and the incidence of cardiovascular disease: Evidence from the UK Biobank cohort study.
    PLoS Med. 2021;18:e1003487.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.